Mr. Dylon Du Plooy

Chief Executive Officer

Present Positions

• Chief Executive Officer of Protext Mobility Inc. protxtm.com
• Chief Executive Officer & Co-Founder of RSAMMD Acquisitions LLC rsammda.com
• Founder & Chief Executive Officer of the Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) rsammd.co.za
• Director of Agricultural Operations & Cultivation Strategy at Leeds Boerdery
• Founder of Zero Harm Foundation zhf.co.za
• Vice Chairman and Treasurer of “WE CARE” NPO

Executive Profile

Mr. Dylon Du Plooy is a South African entrepreneur, global cannabis industry leader, farmer, biotechnology executive, and visionary founder recognized for building and scaling vertically integrated platforms at the convergence of plant-based therapeutics, advanced extraction science, large-scale agricultural operations, and real-world asset (RWA) digital financial infrastructure.

As Chief Executive Officer and Director of Protext Mobility Inc. ($TXTM), Mr. Du Plooy leads the company’s global strategy, overseeing the convergence of biotechnology, pharmaceutical development, agricultural infrastructure, advanced extraction systems, and next-generation financial networks designed to redefine how natural medicines are developed, validated, commercialized, and tokenized worldwide.

With more than a decade of focused experience spanning research, cultivation, pharmaceutical development, capital markets strategy, sustainable agriculture, and international commercialization, Mr. Du Plooy has established a uniquely integrated ecosystem bridging life sciences, global agriculture, extraction technology, digital asset infrastructure, and plant-based healthcare innovation.

His work reflects a long-term mission centered on:

• Human Health
• Scientific Advancement
• Global Accessibility
• Sustainable Value Creation
• Agricultural Development
• Technology-Driven Infrastructure
• Financial Innovation Aligned with Real-World Productivity

Origin & Foundational Philosophy

Mr. Du Plooy’s journey into biotechnology, natural medicine, and plant science began through deeply personal circumstances that would ultimately shape the trajectory of his life and career.

Following his mother’s diagnosis with multiple autoimmune diseases and a pituitary macroadenoma, he was confronted with the limitations of conventional treatment pathways and the devastating emotional realities faced by families navigating chronic illness. Refusing to accept hopelessness as an outcome, he immersed himself in the study of natural medicine, nutrition, human biology, and the teachings of Hippocrates — particularly the principle:

“Let food be thy medicine & medicine be thy food.”

This moment ignited what would become a lifelong commitment toward understanding the relationship between human health, biological systems, natural healing, nutritional science, plant-based therapeutics, scientific innovation, plant compounds, and cannabinoid science.

His philosophy integrates timeless medical principles with modern scientific thinking:

• Health is humanity’s greatest asset
• Balance is essential within both biological and economic systems
• What is used develops, and what is neglected declines
• Everything in excess is opposed by nature
• The natural healing forces within each individual are central to recovery and resilience
• True innovation must ultimately serve humanity

These principles continue to guide both his personal ethos and the strategic direction of the global platforms he leads today.

Founder of RSAMMD & South African Industry Pioneer

Mr. Du Plooy is the visionary founder and Chief Executive Officer of the Republic of South Africa Medical Marijuana Dispensaries (RSAMMD), a pioneering South African enterprise focused on the research, cultivation, production, and distribution of medical cannabis, industrial hemp, and cannabinoid-based products.

At a time when cannabis reform in South Africa remained highly uncertain, he became actively involved in the Cannabis Development Council of South Africa (CDCSA), emerging as an early youth activist and industry participant advocating for:

• Structured Cannabis Reform
• Industry Education
• Agricultural Enablement
• Regulatory Development
• Responsible Industry Participation

His involvement contributed to the broader movement supporting the legalization and constitutional advancement of cannabis in South Africa beginning in 2016 and leading into the landmark constitutional developments of 2018.

Under his leadership, RSAMMD evolved into a vertically integrated operational platform incorporating:

• Licensed Cultivation Infrastructure
• Large-Scale Agricultural Operations
• Pharmaceutical-Grade Processing Capabilities
• Cannabinoid Research & Development
• Global Commercialization Initiatives
• Strategic Partnerships with Hospitals, Universities, and Industry Participants

This created a true seed-to-sale ecosystem designed to support scientific validation, pharmaceutical development, and international scalability.

Agricultural Leadership & Farming Operations

Beyond executive leadership, Mr. Du Plooy remains directly involved in agricultural operations and cultivation strategy through Leeds Boerdery alongside Dr. Ahmed Jamaloodeen and affiliated RSAMMD operations.

Working across licensed farming operations in Newcastle, KwaZulu-Natal, he has played a hands-on role in:

• Industrial Hemp Cultivation
• Large-Scale Cannabis Farm Development
• Agricultural Planning & Field Operations
• Propagation & Genetic Development
• Sustainable Cultivation Methods
• Eco-Farming & Crop Rotation Systems
• Harvest Management & Infrastructure Development
• Production Optimization & Cultivation Strategy

Mr. Du Plooy has been actively involved in the day-to-day agricultural activities associated with planting, cultivation management, operational scaling, and sustainable production systems — helping establish the agricultural foundation underpinning the company’s vertically integrated biotechnology model.

His broader agricultural vision includes:

• Food Security
• Job Creation
• Rural Development
• Zero-Waste Systems
• Sustainable Materials Development
• Environmentally Responsible Farming Practices

This integration of agriculture, biotechnology, and sustainability remains central to his long-term strategic framework.

Scientific Validation & Extraction Technology Breakthroughs

One of the defining milestones in Mr. Du Plooy’s career was the strategic collaboration between RSAMMD and Protext involving the testing and validation of proprietary live plant extraction technology utilizing sonoluminescence-based extraction principles.

Working alongside Dr. Jamaloodeen, Roger Duffield, Dr. Hurley, engineering teams, independent laboratories, and licensed operators, a series of controlled live plant extraction trials were conducted in South Africa using freshly harvested cannabis and hemp biomass sourced directly from licensed cultivation facilities.

The extraction systems were transported directly onto licensed farms, where live cannabis and hemp plants were freshly harvested and processed into nano-emulsified phytocannabinoid extracts under controlled testing conditions.

The trials focused on validating whether live plant extraction at optimized temperature ranges could:

• Preserve Natural Cannabinoid Acid Profiles
• Maintain Full Medicinal Plant Integrity
• Enhance Bioavailability
• Reduce Thermal Degradation
• Produce Non-Psychoactive Full-Spectrum Formulations
• Optimize Therapeutic Delivery

Strategic Healthcare & TruLeaf Partnership

Under Mr. Du Plooy’s leadership, Protext Mobility expanded its strategic healthcare and cannabinoid commercialization initiatives through its partnership with TruLeaf Health, led by Dr. Regina S. Hurley.

The collaboration focused on integrating:

• High-Bioavailability Cannabinoid Formulations
• Nanotechnology-Enhanced Delivery Systems
• Plant-Based Wellness Products
• Advanced API Development
• Global Patient Access Strategies
• Scientifically Validated Cannabinoid Applications

The strategic partnership sought to combine Protext Mobility’s live plant extraction systems and vertically integrated cultivation infrastructure with TruLeaf’s expertise in cannabinoid wellness, clinical pharmacology, nano-emulsified delivery technologies, medical education, and patient-centered healthcare solutions.

The strategic partnership also reinforced Protext Mobility’s broader mission of integrating scientific validation, agricultural infrastructure, medical expertise, and next-generation delivery technologies into scalable systems designed for long-term global healthcare impact.

The Protext Mobility Merger & Corporate Evolution

Mr. Du Plooy played a leading role in the strategic merger and acquisition process involving RSAMMD Acquisitions LLC and Protext Mobility Inc. ($TXTM).

Working alongside Dr. Jamaloodeen, he helped facilitate the integration of:

• Licensed Cultivation Operations
• Farming Infrastructure
• Agricultural Permits & Regulatory Access
• Research & Development Capabilities
• Extraction Technology Access
• International Off-Take Relationships
• Commercialization Strategies
• Pharmaceutical Development Initiatives

The merger created a vertically integrated biotechnology platform combining agricultural production, extraction science, pharmaceutical development, infrastructure, and capital markets access.

Through the merger structure and strategic partnerships, Protext Mobility gained operational access to cultivation licenses, federally permitted farming infrastructure, agricultural assets, extraction development capabilities, and commercialization pathways associated with the RSAMMD ecosystem and affiliated operations.

Mr. Du Plooy subsequently assumed leadership of the combined platform as Chief Executive Officer and Director, guiding its evolution toward a globally scalable biotechnology, agricultural infrastructure, and digital financial systems enterprise.

Real-World Asset (RWA) Tokenization & Digital Financial Infrastructure

A defining evolution under Mr. Du Plooy’s leadership has been the integration of real-world asset (RWA) tokenization into Protext Mobility’s long-term strategic framework.

Recognizing the limitations of traditional financing models within agriculture, biotechnology, and resource-based industries, he has championed systems designed to bridge biological production with digital financial infrastructure.

This framework seeks to transform physical agricultural and pharmaceutical outputs into structured digital assets capable of broader institutional and global market participation.

The strategy focuses on enabling:

• Tokenized Real-World Agricultural Assets
• Digital Representation of Biological Outputs
• Fractionalized Ownership Structures
• Global Capital Access
• Enhanced Liquidity Systems
• Cross-Border Participation
• Blockchain-Enabled Transparency & Traceability

Through this convergence of biotechnology, agriculture, infrastructure, and decentralized financial systems, Mr. Du Plooy has positioned Protext Mobility within an emerging category of bio-financial infrastructure platforms.

Institutional Discipline & Corporate Governance

Mr. Du Plooy has consistently emphasized disciplined corporate governance and long-term shareholder alignment.

Under his leadership, the company has implemented several structural principles including:

• Zero-Debt Capital Structure
• No Executive Salaries Since Inception
• No Reverse Stock Splits
• Continued Insider Participation & Accumulation
• Long-Term Value Creation Focus

The company continues progressing toward:

• IFRS-Compliant Audited Financials
• Third-Party Valuation Frameworks
• Enhanced Transparency Standards
• Institutional Governance Structures
• Potential Uplisting Objectives

This governance philosophy reflects a broader commitment toward building durable infrastructure, responsible growth systems, and long-term enterprise value.

Global Positioning & Strategic Advantage

Mr. Du Plooy has strategically positioned operations to leverage South Africa’s agricultural and economic advantages within the global cannabis and hemp industries.

These advantages include:

• Favorable Climate Conditions
• Large-Scale Cultivation Capacity
• Access to Licensed Farming Infrastructure
• Cost Efficiencies Through USD/ZAR Dynamics
• Access to Emerging & Developed Global Markets
• Expanding International Demand for Cannabis & Hemp Products

Combined with proprietary extraction methodologies, vertically integrated infrastructure, and strategic healthcare partnerships, this positioning creates a scalable framework across:

• Cultivation
• Processing
• Pharmaceutical Development
• Export Logistics
• Digital Infrastructure
• Global Commercialization

Zero Harm Foundation & Humanitarian Vision

Mr. Du Plooy is also the Founder of the Zero Harm Foundation, a global initiative focused on:

• Sustainability
• Human Upliftment
• Health
• Systemic Impact
• Responsible Development
• Global Collaboration

The foundation operates on the principle of achieving “Zero Harm” across environmental, social, and economic systems through:

• Sustainable Development
• Education & Human Development
• Environmental Stewardship
• Health-Centered Initiatives
• Responsible Resource Utilization
• Long-Term Planetary Resilience

He also serves as Vice Chairman and Treasurer of WE CARE NPO.

Vision

Mr. Du Plooy’s long-term vision centers on building integrated systems where:

• Natural Medicine Meets Advanced Science
• Agriculture Integrates with Digital Infrastructure
• Biological Assets Become Globally Accessible
• Capital Flows More Efficiently Across Borders
• Technology Serves Human Health & Sustainability
• Financial Systems Align with Real Economic Productivity

His objective is not simply to build a company, but to establish scalable systems capable of integrating:

• Biology
• Science
• Agriculture
• Infrastructure
• Medical Innovation
• Financial Networks

into platforms designed for long-term global impact.

Summary

Mr. Dylon Du Plooy stands as a South African pioneer, global cannabis industry leader, farmer, biotechnology executive, and visionary founder operating at the intersection of:

• Science
• Agriculture
• Biotechnology
• Healthcare
• Infrastructure
• Financial Innovation

Through Protext Mobility Inc., RSAMMD, and affiliated initiatives, he continues advancing a vertically integrated ecosystem focused on:

• Plant-Based Pharmaceutical Development
• Advanced Extraction Science
• Large-Scale Cultivation & Agriculture
• Sustainable Infrastructure
• Tokenized Real-World Asset Systems
• Global Commercialization Networks
• Patient-Centered Healthcare Solutions

His mission remains clear:

To advance human health, build sustainable systems, unlock global value, and create infrastructure that serves both humanity and the future of the planet.

#TeamHumanity⚛️
#TeamCannabisSouthAfrica🌍